KeiwaKEIWA Incorporated4251東証プライム化学FY ending Dec 2025, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥21 is left as operating profit. Revenue changed -3.1% from the prior year, operating profit -9.6%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2021 | 14.2% | 0.63× | 8.9% | 2.08× | 18.6% |
| 2022 | 23.0% | 0.73× | 16.7% | 1.80× | 30.1% |
| 2023 | 11.3% | 0.60× | 6.8% | 1.53× | 10.4% |
| 2024 | 13.2% | 0.69× | 9.1% | 1.47× | 13.4% |
| 2025 | 11.1% | 0.65× | 7.2% | 1.41× | 10.1% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18,131 | 21,103 | 17,570 | 21,130 | 20,473 |
| Cost of revenue | 10,924 | 10,911 | 10,332 | 11,245 | 11,692 |
| Gross profit | 7,207 | 10,192 | 7,238 | 9,885 | 8,781 |
| SG&A | 4,071 | 4,622 | 4,782 | 5,145 | 4,494 |
| Operating income | 3,135 | 5,570 | 2,456 | 4,740 | 4,287 |
| Pretax income | 3,271 | 6,700 | 2,760 | 3,927 | 3,224 |
| Income tax | 702 | 1,839 | 777 | 1,137 | 955 |
| Net income attributable to owners | 2,570 | 4,861 | 1,983 | 2,791 | 2,269 |
| Operating margin | 17.3% | 26.4% | 14.0% | 22.4% | 20.9% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥8.9B | ¥9.99B | ¥7.38B | ¥9.64B | ¥7.54B |
| Total assets | ¥28.8B | ¥29.3B | ¥29.3B | ¥32B | ¥30.9B |
| Net assets | ¥14.1B | ¥18.9B | ¥20.4B | ¥23B | ¥23.9B |
| Share capital | ¥3.86B | ¥3.87B | ¥3.88B | ¥3.89B | ¥3.89B |
| Trade receivables | ¥5.31B | ¥4.46B | ¥4.93B | ¥4.31B | ¥5.14B |
| Property, plant and equipment | ¥10.1B | ¥10.5B | ¥12.1B | ¥12.2B | ¥12.4B |
| Intangible assets excluding goodwill | ¥84.8M | ¥525.9M | ¥469.8M | ¥383.2M | ¥313.9M |
| Investment securities | ¥152.1M | ¥123.3M | ¥131.3M | ¥147.9M | ¥175.5M |
| Current assets | ¥18B | ¥17.9B | ¥16.3B | ¥18.9B | ¥17.8B |
| Current liabilities | ¥9.54B | ¥6.66B | ¥5.84B | ¥7B | ¥4.6B |
| Trade payables | ¥2.01B | ¥1.18B | ¥1.41B | ¥1.37B | ¥1.23B |
| Long-term borrowings | ¥4.64B | ¥3.4B | ¥2.71B | ¥1.53B | ¥1.29B |
| Total liabilities | ¥14.6B | ¥10.4B | ¥8.91B | ¥9.05B | ¥7.08B |
| Equity attributable to owners of parent | ¥13.8B | ¥18.5B | ¥19.7B | ¥22.1B | ¥22.7B |
| Retained earnings | ¥6.32B | ¥10.9B | ¥12.2B | ¥14.5B | ¥16.1B |
| Treasury stock | -¥448K | -¥666K | -¥709K | -¥803K | -¥944.4M |
EDINET (FSA Japan)
有価証券報告書－第79期(2025/01/01－2025/12/31)
EDINET (FSA Japan)
訂正有価証券報告書－第78期(2024/01/01－2024/12/31)
EDINET (FSA Japan)
有価証券報告書－第77期(2023/01/01－2023/12/31)
EDINET (FSA Japan)
有価証券報告書－第76期(2022/01/01－2022/12/31)
EDINET (FSA Japan)
有価証券報告書－第75期(令和3年1月1日－令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書－第74期(令和2年1月1日－令和2年12月31日)
Extracted from XBRL: 51 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.